Примери за използване на Is not metabolised на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Cefuroxime is not metabolised.
The active moiety of Velphoro, pn-FeOOH, is not metabolised.
Cefuroxime is not metabolised.
Radium-223 is an isotope which decays and is not metabolised.
Fluciclovine is not metabolised in vivo.
Metabolism: Cefuroxime is not metabolised.
Ganciclovir is not metabolised to a significant extent.
As a divalent cation,strontium is not metabolised.
Pravastatin is not metabolised by CYP450.
Trifluridine is a substrate of TPase, but is not metabolised by cytochrome P450(CYP).
As tobramycin is not metabolised, an effect of hepatic impairment on the exposure to tobramycin is not expected.
Hydrochlorothiazide is not metabolised in man.
As strontium ranelate is not metabolised, no dose adjustment is required in patients with hepatic impairment.
Lixisenatide is a peptide and is not metabolised by cytochrome P450.
Pravastatin is not metabolised by CYP3A4.
Ceftazidime is not metabolised.
Etelcalcetide is not metabolised by CYP450 enzymes.
In vitro, tenofovir alafenamide is not metabolised by CYP1A2, CYP2C8, CYP2C9, CYP2C19, or CYP2D6.
Use in hepatic impairment As strontium ranelate is not metabolised, no dosage adjustment is required in patients with hepatic impairment.
Tipiracil hydrochloride was not metabolised in human liver S9 or in cryopreserved human hepatocytes.
N-desmethyl enzalutamide was not metabolised by CYPs in vitro.
In in vitro studies,daptomycin was not metabolised by human liver microsomes.
Tenofovir and tenofovir disoproxil are not metabolised by liver enzymes.
In vitro tests showed that plerixafor was not metabolised by P450 CYP enzymes, did not inhibit or induce P450 CYP enzymes.
For those benzodiazepines which are not metabolised by CYP3A4(temazepam, nitrazepam, lorazepam) an interaction with Ketek is unlikely.
Dabigatran etexilate and dabigatran are not metabolised by the cytochrome P450 system and have no in vitro effects on human cytochrome P450 enzymes.
Under the influence of grapefruit these drugs are not metabolised in the gut, causing their concentration in blood increases.
Ceftaroline or ceftaroline fosamil are not metabolised by CYP450 enzymes in vitro, therefore co-administered CYP450 inducers or inhibitors are unlikely to influence the pharmacokinetics of ceftaroline.
Changes in hepatic function are unlikely to have any effect on the elimination of daratumumab since IgG1 molecules such as daratumumab are not metabolised through hepatic pathways.
As monoclonal antibodies are not metabolised by cytochrome P450(CYP) enzymes or other drug metabolising enzymes, inhibition or induction of these enzymes by co-administered medicinal products is not anticipated to affect the pharmacokinetics of olaratumab.